Clinical trial
ENvarsus for Impaired Glucose Tolerance Post REnal transplAnT
NCT04973982 is registered in ClinicalTrials.gov with Barts & The London NHS Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ENvarsus for Impaired Glucose Tolerance Post REnal transplAnT
- Lead sponsor
- Barts & The London NHS Trust
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- January 31, 2022
- Completion date
- October 1, 2022
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
renal transplant failure